| > The way a market works is people find ways to serve people at a price they can afford. When you always force others to pay for the cadillac service for them, no one bothers to find cheap ways to provide healthcare. How can you be so twisted up about this? Americas system is the expensive one, everyone else's is cheap, and controlling costs better. Medicare may not be doing a perfect job but again it's controlling costs better than the private sector. What you are saying is strictly and objectively false. Healthcare is optimized and improved in single-payer states, because there's still budgets. You're defending the worst system out there from a cost perspective, and not top 20 in outcomes. And you're doing so by saying the system other countries are successfully using to control costs would fail to control costs, and using this to defend American's failure to control costs? You're telling me Canada is doing a bad job of controlling costs when it literally costs half as much per capita? Because their rate of cost growth is in line with their peers while America's is way, way beyond? Your mental gymnastics are giving me a headache. > Venezuela is just a difference of degree. The same effect is seen in everyone's lack of R&D spending outside the US. And that? Also false. Venezuela is a difference of degree? What on earth are you talking about. R&D spending? Guess which healthcare companies spend the most on R&D? It's not the American ones. It's all the European ones. #1 is Switzerland's Roche. #4 is Switzerland's Novartis. #6 is France's Sanofi. #9 is the UK's AstraZeneca. #10 is the UK's GlaxoSmithKlein. [1] This is yet another failed talking point. Guess which country developed the first COVID vaccine? Germany. BioNTech's vaccine was paid for by Germany's government. Pfizer took $0 of US money and is productionizing a Turkish immigrant in Germany's German government funded research work. You're just not right about this one, time to move on lol. [1] https://www.fiercebiotech.com/special-report/top-10-pharma-r... |
Roche has over 8000 employees in the US. https://www.roche.com/careers/our-locations/americas/usa.htm
A handful of giant international companies who obviously make a big fraction of their money in the US market (selling at higher prices due to the lack of price fixing) do not provide a useful metric. Try overall stats, such as here: https://efpia.eu/publications/data-center/the-pharma-industr...
And that'd just pharmaceuticals. The US has far greater dominance over other areas of biotech.
But you're right, I do need to move on. This immature flaming behavior is why I avoid toxic places like reddit.